TNDM earnings
Tandem Diabetes (TNDM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
TNDM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.31 | -0.32 | 3.35% | $254.56M |
| Q1 2026 | May 7, 2026 | -0.30 | -0.46 | 34.78% | $247.22M |
| Q4 2025 | Feb 19, 2026 | -0.01 | -0.05 | 80.00% | $290.38M |
| Q3 2025 | Nov 6, 2025 | -0.31 | -0.31 | 0.00% | $249.25M |
| Q2 2025 | Aug 6, 2025 | -0.48 | -0.40 | -20.00% | $240.68M |
| Q1 2025 | Apr 30, 2025 | -0.67 | -0.60 | -11.67% | $234.42M |
| Q4 2024 | Feb 26, 2025 | 0.01 | -0.23 | 104.35% | $282.65M |
| Q3 2024 | Nov 6, 2024 | -0.35 | -0.40 | 12.50% | $363.29M |
| Q2 2024 | Aug 1, 2024 | -0.48 | -0.54 | 11.11% | $221.91M |
| Q1 2024 | May 2, 2024 | -0.63 | -0.76 | 17.11% | $191.67M |
| Q4 2023 | Feb 21, 2024 | -0.27 | -0.25 | -8.00% | $196.80M |
| Q3 2023 | Oct 31, 2023 | -0.38 | -0.34 | -11.76% | $185.62M |
| Aug 2, 2023 | -0.55 | -0.54 | -1.85% | – | |
| May 3, 2023 | -1.92 | -0.56 | -242.86% | – | |
| Feb 22, 2023 | -0.01 | -0.02 | 50.00% | – | |
| Nov 2, 2022 | -0.76 | -0.05 | -1420.00% | – | |
| Aug 3, 2022 | -0.24 | 0.02 | -1300.00% | – | |
| May 4, 2022 | -0.23 | -0.07 | -228.57% | – | |
| Feb 22, 2022 | 0.16 | 0.21 | -23.81% | – | |
| Nov 3, 2021 | 0.09 | 0.06 | 50.00% | – |
- TNDM reports next on Nov 5, 2026, with EPS of -0.25 expected.
- TNDM beat EPS estimates in 28 of its last 51 reports.
Updated 2026-11-02 23:13 UTC